Limitations of the α-Synuclein Seed Amplification Assay in Clinical Practice
Huw R. Morris, Andrew Lees
Abstract
This Viewpoint cautions against premature adoption of the α-synuclein seed amplification assay as a biomarker test for Parkinson disease in general neurology practice.
Topics & Concepts
BiomarkerNeurologyClinical PracticeMedicineDiseaseParkinson's diseaseOncologyBiologyNeuroscienceInternal medicineGeneticsFamily medicineParkinson's Disease Mechanisms and TreatmentsNeurological disorders and treatmentsAutism Spectrum Disorder Research